C57BL/6-Il1r1tm1.1Wme/Flmg

Status

Available to order

EMMA IDEM:10980
Citation informationRRID:IMSR_EM:10980 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameC57BL/6-Il1r1tm1.1Wme/Flmg
Alternative nameB6-Il1r1/UmanFlmg
Strain typeTargeted Mutant Strains : Conditional mutation
Allele/Transgene symbolIl1r1tm1.1Wme
Gene/Transgene symbolIl1r1

Information from provider

ProviderWerner Muller
Provider affiliationFaculty of Biology, Medicine and Health Science, University of Manchester
Genetic informationA targeting vector, encoding two loxP sites flanking exon 5 of the Il1r1 gene, was inserted. An FRT-flanked neomycin resistance (neo) cassette was placed downstream of the 3' loxP site. The gene targeting event was confirmed by PCR analysis. Flp-mediated recombination removed the FRT-flanked neo cassette.
Phenotypic informationHomozygous:
No overt phenotype

Heterozygous:
No overt phenotype
References
  • Characterization of a conditional interleukin-1 receptor 1 mouse mutant using the Cre/LoxP system.;Abdulaal Wesam H, Walker Catherine R, Costello Ryan, Redondo-Castro Elena, Mufazalov Ilgiz A, Papaemmanouil Athina, Rothwell Nancy J, Allan Stuart M, Waisman Ari, Pinteaux Emmanuel, Müller Werner, ;2016;European journal of immunology;46;912-8; 26692072
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreB.S.R.C. Alexander Fleming, Vari, Greece
Animals used for archivinghomozygous C57BL/6 males

Disease and phenotype information

IMPC phenotypes (gene matching)
  • abnormal spleen morphology / IMPC
  • increased kidney weight / IMPC
  • enlarged heart / IMPC
  • enlarged kidney / IMPC
  • abnormal heart morphology / IMPC
  • abnormal kidney morphology / IMPC
  • enlarged spleen / IMPC
MGI phenotypes (gene matching)
  • decreased neutrophil cell number / MGI
  • abnormal cell death / MGI
  • increased body length / MGI
  • increased body weight / MGI
  • weight loss / MGI
  • decreased anxiety-related response / MGI
  • hypoactivity / MGI
  • abnormal inflammatory response / MGI
  • increased circulating insulin level / MGI
  • no abnormal phenotype detected / MGI
  • abnormal nervous system electrophysiology / MGI
  • increased susceptibility to bacterial infection / MGI
  • decreased immunoglobulin level / MGI
  • abnormal neutrophil physiology / MGI
  • enhanced wound healing / MGI
  • increased growth rate / MGI
  • increased liver weight / MGI
  • delayed tooth eruption / MGI
  • increased susceptibility to age related obesity / MGI
  • decreased susceptibility to induced arthritis / MGI
  • abnormal response/metabolism to endogenous compounds / MGI
  • increased susceptibility to induced arthritis / MGI
  • impaired febrile response / MGI
  • abnormal lean body mass / MGI
  • decreased susceptibility to kidney reperfusion injury / MGI
  • decreased incidence of tumors by chemical induction / MGI
  • increased circulating insulin-like growth factor I level / MGI
  • decreased susceptibility to autoimmune diabetes / MGI
  • decreased susceptibility to experimental autoimmune uveoretinitis / MGI
  • abnormal vascular wound healing / MGI
  • increased bone resorption / MGI
  • decreased eosinophil cell number / MGI
  • decreased T cell number / MGI
  • sepsis / MGI
  • decreased T cell proliferation / MGI
  • osteomyelitis / MGI
  • impaired glucose tolerance / MGI
  • insulin resistance / MGI
  • homeostasis/metabolism phenotype / MGI
  • immune system phenotype / MGI
  • abnormal food intake / MGI
  • increased percent body fat/body weight / MGI
  • decreased circulating creatinine level / MGI
  • decreased blood urea nitrogen level / MGI
  • decreased susceptibility to type IV hypersensitivity reaction / MGI
  • increased circulating leptin level / MGI
  • increased body mass index / MGI
  • decreased tumor necrosis factor secretion / MGI
  • decreased circulating interleukin-6 level / MGI
  • increased circulating interleukin-18 level / MGI
  • decreased circulating interleukin-18 level / MGI
  • increased circulating interleukin-1 beta level / MGI
  • decreased interleukin-6 secretion / MGI
  • impaired neutrophil chemotaxis / MGI
  • decreased transforming growth factor level / MGI
  • increased gonadal fat pad weight / MGI
  • increased abdominal fat pad weight / MGI
  • increased inguinal fat pad weight / MGI
  • increased mesenteric fat pad weight / MGI
  • increased retroperitoneal fat pad weight / MGI
  • enhanced contextual conditioning behavior / MGI
  • increased susceptibility to bacterial infection induced morbidity/mortality / MGI
  • increased total body fat amount / MGI
  • abnormal circulating serum amyloid protein level / MGI
  • increased respiratory quotient / MGI
  • abnormal microglial cell activation / MGI
  • integument phenotype / MGI
  • dental pulp necrosis / MGI

Literature references

  • Characterization of a conditional interleukin-1 receptor 1 mouse mutant using the Cre/LoxP system.;Abdulaal Wesam H, Walker Catherine R, Costello Ryan, Redondo-Castro Elena, Mufazalov Ilgiz A, Papaemmanouil Athina, Rothwell Nancy J, Allan Stuart M, Waisman Ari, Pinteaux Emmanuel, Müller Werner, ;2016;European journal of immunology;46;912-8; 26692072

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).